IP Library Patent Application 13140794
Patent Application
App. No. 13/140,794

FEED SUPPLEMENT FOR MAMMALIAN CELL CULTURE AND METHODS OF USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/140,794
Abstract

An improved feed supplement for culture of mammalian cells used to produce proteins is provided. The improved supplement is devoid of animal-derived components and protein hydrolysates. The invention also provides methods of using the supplement in production of a therapeutic proteins, such as an antibody. In some embodiments, the antibody is an anti-human IL-23p19 antibody.

Claims (28)

1 . A cell feed supplement concentrate comprising components 1-47 of Table 3 and;

a) sodium selenite; or

b) vitamin E.

2 . The supplement of claim 1 comprising sodium selenite and vitamin E.

3 . The supplement of claim 1 , wherein the sodium selenite is present at approximately 0.3 mg/L.

4 . The supplement of claim 1 , wherein the vitamin E is present at approximately 30.2 mg/L.

5 . A method of producing a protein comprising culturing cells in growth medium supplemented with the supplement of claim 1 .

6 . A method of producing a protein comprising:

a) growing mammalian cells expressing the protein in culture;

b) supplementing the culture with the supplement of claim 1 ; and

c) recovery of the protein from the culture.

7 . The method of claim 6 further comprising shifting the temperature of the culture from 37° C. to 34° C.

8 . The method of claim 7 wherein the shifting of the temperature is performed on day 3, day 4 or day 5 after inoculation.

9 . The method of claim 6 wherein the supplementing step (b) is repeated an additional two or more times.

10 . The method of claim 10 wherein the supplementing steps are performed on days 3, 5 and 10 after inoculation.

11 . The method of claim 5 or 6 wherein the cells are CHO cells.

12 . The method of claim 5 or 6 wherein the protein is an antibody or antigen-binding fragment thereof.

13 . The method of claim 12 wherein the antibody or antigen-binding fragment thereof comprises a human IgG constant domain.

14 . The method of claim 12 wherein the antibody, or antigen-binding fragment thereof, specifically binds to human IL-23p19.

15 . The method of claim 14 wherein the antibody, or antigen-binding fragment thereof, comprises at least one heavy chain CDR, and at least one light chain CDR, of antibody hu13B8b disclosed in International Pat. Appl. Pub. No. WO 2008/103432.

16 . A method of producing a protein comprising:

a) growing mammalian cells expressing the protein in culture;

b) supplementing the culture with sodium selenite or vitamin E; and

c) obtaining the protein from the cell culture.

17 . The method of claim 16 wherein the culture is supplemented with sodium selenite and vitamin E.

18 . The method of claim 16 , wherein the sodium selenite is added to the culture to give a final concentration of approximately 0.02 mg/L.

19 . The method of claim 16 , wherein the vitamin E is added to the culture to give a final concentration of approximately 2 mg/L.

20 . The method of claim 16 , wherein the sodium selenite is added to the culture to give a final concentration of approximately 0.02 mg/L and the vitamin E is added to the culture to give a final concentration of approximately 2 mg/L.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →